OPTIMIZERx Corp OPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/20/24 EDT
13.08quote price arrow up+0.39 (+3.07%)
Volume
226,053
52 week range
6.92 - 16.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.08
  • 52 Week High16.65
  • 52 Week High Date03/08/24
  • 52 Week Low6.92
  • 52 Week Low Date10/09/23

Key Stats

  • Market Cap237.846M
  • Shares Out18.18M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-8.6

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.08
  • 52 Week High16.65
  • 52 Week High Date03/08/24
  • 52 Week Low6.92
  • 52 Week Low Date10/09/23
  • Market Cap237.846M
  • Shares Out18.18M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-8.6

RATIOS/PROFITABILITY

  • EPS (TTM)-1.03
  • P/E (TTM)-12.70
  • Fwd P/E (NTM)53.39
  • EBITDA (TTM)-12.483M
  • ROE (TTM)-14.66%
  • Revenue (TTM)78.209M
  • Gross Margin (TTM)60.95%
  • Net Margin (TTM)-23.10%
  • Debt To Equity (MRQ)29.31%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OPTIMIZERx Corp

 

Profile

MORE
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care...
Lynn Vos
Independent Chairperson of the Board
William Febbo
Chief Executive Officer, Director
Stephen Silvestro
President, Chief Commercial Officer
Edward Stelmakh
Chief Financial Officer, Chief Operating Officer
Todd Inman
Chief Technology Officer
Address
260 CHARLES STREET, SUITE 302
Waltham, MA
02453
United States

Top Peers

SYMBOLLASTCHG%CHG
SOPH
Sophia Genetics SA
4.55+0.01+0.22%
AUGX
Augmedix Inc
1.16-0.05-4.13%
CSBR
Champions Oncology Inc
4.76+0.06+1.28%
CCEL
Cryo-Cell International Inc
8.94-0.06-0.67%
FORA
Forian Inc
2.67+0.01+0.34%